Your browser doesn't support javascript.
loading
Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions.
Thota, Swapna; Patel, Bhumika J; Sadaps, Meena; Balasubramanian, Suresh; Sanikommu, Srinivasa; Hirsch, Cassandra; Marotta, Serena; Sekeres, Mikkael A; Risitano, Antonio M; Maciejewski, Jaroslaw P.
Afiliação
  • Thota S; Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Patel BJ; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Sadaps M; Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Balasubramanian S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Sanikommu S; Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Hirsch C; Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Marotta S; Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Sekeres MA; Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
  • Risitano AM; Haematology, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
  • Maciejewski JP; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
Br J Haematol ; 183(1): 133-136, 2018 10.
Article em En | MEDLINE | ID: mdl-28905372
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças da Medula Óssea / Alemtuzumab Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças da Medula Óssea / Alemtuzumab Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos